Home
International Journal of Science and Research Archive
International, Peer reviewed, Open access Journal ISSN Approved Journal No. 2582-8185

Main navigation

  • Home
    • Journal Information
    • Abstracting and Indexing
    • Editorial Board Members
    • Reviewer Panel
    • Journal Policies
    • IJSRA CrossMark Policy
    • Publication Ethics
    • Issue in Progress
    • Current Issue
    • Past Issues
    • Instructions for Authors
    • Article processing fee
    • Track Manuscript Status
    • Get Publication Certificate
    • Become a Reviewer panel member
    • Join as Editorial Board Member
  • Contact us
  • Downloads

ISSN Approved Journal || eISSN: 2582-8185 || CODEN: IJSRO2 || Impact Factor 8.2 || Google Scholar and CrossRef Indexed

Peer Reviewed and Referred Journal || Free Certificate of Publication

Research and review articles are invited for publication in March 2026 (Volume 18, Issue 3) Submit manuscript

Lithium treatment and hyperparathyroidism: Clinical implications and management

Breadcrumb

  • Home
  • Lithium treatment and hyperparathyroidism: Clinical implications and management

Roberto Lozano 1, * and Carina Bona 2

1 Department of Pharmacy, University clinical hospital“Lozano Blesa”, Zaragoza, Spain. 

2 Unit for the Rational Use of Medicines, Aragon Health Service, Zaragoza, Spain.

Review Article

International Journal of Science and Research Archive, 2025, 16(03), 1338-1341

Article DOI: 10.30574/ijsra.2025.16.3.2739

DOI url: https://doi.org/10.30574/ijsra.2025.16.3.2739

Received on 23 August 2025; revised on 28 September 2025; accepted on 30 September 2025

Objective: To analyze the association between chronic lithium treatment and hyperparathyroidism, exploring pathophysiological mechanisms, clinical manifestations, diagnostic approaches, and management strategies. 

Methods: A review of clinical cases and literature evidence is presented, integrating findings from real-world psychiatric populations. 

Results: Lithium use was associated with elevated serum calcium and parathyroid hormone (PTH) levels, increasing the risk of nephrolithiasis, osteoporosis, and cardiovascular complications. 

Discussion: Hyperparathyroidism secondary to lithium therapy represents a significant but often overlooked adverse effect. Its detection requires systematic biochemical monitoring and clinical awareness. Conclusion: Regular calcium and PTH assessments are recommended in patients receiving lithium, with individualized management strategies including dose adjustment, medical therapy, or parathyroidectomy in selected cases.

Lithium; Hyperparathyroidism; Bipolar disorder; Calcium metabolism; Endocrine side effects

https://ijsra.net/sites/default/files/fulltext_pdf/IJSRA-2025-2739.pdf

Preview Article PDF

Roberto Lozano and Carina Bona. Lithium treatment and hyperparathyroidism: Clinical implications and management. International Journal of Science and Research Archive, 2025, 16(03), 1338-1341. Article DOI: https://doi.org/10.30574/ijsra.2025.16.3.2739.

Copyright © Author(s). All rights reserved. This article is published under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits use, sharing, adaptation, distribution, and reproduction in any medium or format, as long as appropriate credit is given to the original author(s) and source, a link to the license is provided, and any changes made are indicated.


All statements, opinions, and data contained in this publication are solely those of the individual author(s) and contributor(s). The journal, editors, reviewers, and publisher disclaim any responsibility or liability for the content, including accuracy, completeness, or any consequences arising from its use.

Get Certificates

Get Publication Certificate

Download LoA

Check Corssref DOI details

Issue details

Issue Cover Page

Editorial Board

Table of content

          

   

Copyright © 2026 International Journal of Science and Research Archive - All rights reserved

Developed & Designed by VS Infosolution